Molecular profiles of progesterone receptor loss in human breast tumorsChad J. Creighton, Rachel Schiff, C. Kent Osborne et al.|Breast Cancer Research and Treatment|2008Cited by 126
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Susan G. Hilsenbeck et al.|Clinical Cancer Research|2015Cited by 119
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistanceAgostina Nardone, Rachel Schiff, Hazel M. Weir et al.|British Journal of Cancer|2018Cited by 65
Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancerWen Bu, Yi Li, Jun Chen et al.|Oncogene|2011Cited by 61
Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cellsJinfeng Suo, Eric C. Chang, Daniel Medina et al.|Cell & Bioscience|2015Cited by 12